These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12146122)

  • 1. The prevention and treatment of opportunistic infections in HIV-infected adults.
    HIV Clinician Society of Southern Africa
    S Afr Med J; 2002 Jun; 92(6):426-8. PubMed ID: 12146122
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection.
    Kovacs JA; Masur H
    N Engl J Med; 2000 May; 342(19):1416-29. PubMed ID: 10805828
    [No Abstract]   [Full Text] [Related]  

  • 3. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Bender MA; Sax PE
    N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomised, placebo-controlled trial to evaluate co-trimoxazole to reduce mortality and morbidity in HIV-infected post-natal women in Zambia (TOPAZ).
    Nunn AJ; Mwaba PB; Chintu C; Crook AM; Darbyshire JH; Ahmed Y; Zumla AI
    Trop Med Int Health; 2011 Apr; 16(4):518-26. PubMed ID: 21281407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily trimethoprim-sulfamethoxazole prophylaxis rapidly induces corresponding resistance among intestinal Escherichia coli of HIV-infected adults in Kenya.
    Chiller TM; Polyak CS; Brooks JT; Williamson J; Ochieng B; Shi YP; Ouma P; Greene C; Hamel M; Vulule J; Bopp C; Slutsker L; Mintz E
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):165-9. PubMed ID: 19357424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: impact on risk for infectious diseases.
    Dworkin MS; Williamson J; Jones JL; Kaplan JE;
    Clin Infect Dis; 2001 Aug; 33(3):393-8. PubMed ID: 11438910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi.
    Zachariah R; Spielmann MP; Harries AD; Gomani P; Bakali E
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1046-50. PubMed ID: 12546111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protect yourself from Pneumocystis carinii.
    AIDS Alert; 1999 Jun; 14(6):suppl 1-2. PubMed ID: 11366414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotrimoxazole prophylaxis in HIV-infected pregnant women: only a first step.
    Heather Watts D; Mofenson LM
    J Infect Dis; 2006 Dec; 194(11):1478-80. PubMed ID: 17083031
    [No Abstract]   [Full Text] [Related]  

  • 10. Consensus on use of co-trimoxazole.
    Trop Doct; 2001 Jul; 31(3):189-90. PubMed ID: 11444358
    [No Abstract]   [Full Text] [Related]  

  • 11. [Exanthema in multiple therapy in HIV infection].
    Weisser M
    Praxis (Bern 1994); 1998 May; 87(20):702-4. PubMed ID: 9633229
    [No Abstract]   [Full Text] [Related]  

  • 12. Managing a patient with progressive HIV disease.
    Blais FX
    J Am Osteopath Assoc; 1992 Oct; 92(10):1267-8. PubMed ID: 1459873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Le Moal G; Breux JP; Roblot F
    N Engl J Med; 2001 May; 344(21):1639-41. PubMed ID: 11374363
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergistic pandemics: confronting the global HIV and tuberculosis epidemics.
    Mayer KH; Dukes Hamilton C
    Clin Infect Dis; 2010 May; 50 Suppl 3():S67-70. PubMed ID: 20397958
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
    Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
    Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumocystis choroiditis.
    Gupta A; Hustler A; Herieka E; Matthews BN
    Eye (Lond); 2010 Jan; 24(1):178. PubMed ID: 19325571
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients.
    Jung AC; Paauw DS
    Arch Intern Med; 1994 Nov; 154(21):2402-6. PubMed ID: 7979835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can I stop my PCP prophylaxis?
    Gaylord G
    Posit Living; 1999 Mar; 8(2):22. PubMed ID: 12492001
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotics and HIV. Healing infection without hindering HAART.
    Briggs JM; Narsavage GL
    Adv Nurse Pract; 2004 Jul; 12(7):26-34; quiz 35. PubMed ID: 15315057
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
    Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
    N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.